Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
65–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Male or female participants ≥65 years of age at the time of consent
Adults determined by clinical assessment, including medical history and clinical judgment, to be eligible for the study, including adults with preexisting stable disease
Adults who have no history of ever receiving a pneumococcal vaccine, or have a history of receiving a licensed pneumococcal vaccination ≥6 months prior to first study vaccination.
You may not be if
History of severe adverse reaction associated with a vaccine and/or severe allergic reaction (eg, anaphylaxis)
Previous vaccination with any investigational pneumococcal vaccine, or planned receipt of any licensed or investigational pneumococcal vaccine through study participation.
Vaccination with any influenza or pneumococcal vaccine \<6 months before investigational product administration, or planned receipt of any licensed or investigational non-study influenza vaccine during study participation.
\-- Serious chronic disorder, that in the investigator's opinion would make the participant inappropriate for entry into the study
Other acute or chronic medical or psychiatric condition or laboratory abnormality that may increase the risk associated with study participation or investigational product administration or may interfere with the interpretation of study results
Clareo Health | Safety and Immunogenicity of 20vPnC Coadministered With SIIV in Adults ≥65 Years of Age
